Johnson & Johnson buy Palapper
Start price
08.02.21
/
80%
€137.96
Target price
08.02.22
€160.00
Performance (%)
8.94%
End price
08.02.22
€150.30
Summary
This prediction ended on 08.02.22 with a price of €150.30. The BUY prediction by Palapper finished with a performance of 8.94%. A total of €3.54 was paid as dividends for this prediction. Palapper has 80% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Johnson & Johnson | -0.044% | -0.044% | -9.124% | 0.058% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
Comments by Palapper for this prediction
In the thread Johnson & Johnson diskutieren
Buy mit Kursziel 160,0
In the thread Trading Johnson & Johnson
Die von Palapper gewählte maximale Laufzeit wurde überschritten